in this double-blind , randomized trial involving 143 patients with osteoarthritis of the hip and/or knee , the efficacy and safety of twice-daily dosing with flurbiprofen ( ansaid , upjohn ) , which has a half-life of 5.5 hours , were compared with those of sulindac , which has a half-life of 7.8 hours .
C0016377
flurbiprofen
C0700848
ansaid